Market Closed -
Japan Exchange
02:00:00 2024-05-17 am EDT
|
5-day change
|
1st Jan Change
|
2,438
JPY
|
+0.87%
|
|
+4.50%
|
+12.84%
|
Fiscal Period: February |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
298,871
|
315,869
|
458,659
|
401,788
|
343,804
|
441,176
|
-
|
-
|
Enterprise Value (EV)
1 |
233,560
|
224,522
|
371,814
|
329,957
|
273,162
|
425,161
|
377,403
|
369,771
|
P/E ratio
|
16.8
x
|
15.2
x
|
21.7
x
|
20.7
x
|
18.3
x
|
19.3
x
|
18
x
|
16.7
x
|
Yield
|
1.45%
|
1.57%
|
1.08%
|
1.23%
|
1.4%
|
1.13%
|
1.35%
|
1.5%
|
Capitalization / Revenue
|
0.61
x
|
0.58
x
|
0.76
x
|
0.64
x
|
0.51
x
|
0.57
x
|
0.52
x
|
0.48
x
|
EV / Revenue
|
0.48
x
|
0.41
x
|
0.62
x
|
0.53
x
|
0.41
x
|
0.57
x
|
0.45
x
|
0.41
x
|
EV / EBITDA
|
7.03
x
|
5.88
x
|
8.52
x
|
7.6
x
|
6.21
x
|
7.51
x
|
7.06
x
|
6.39
x
|
EV / FCF
|
439
x
|
8.34
x
|
77.9
x
|
-19.7
x
|
18.2
x
|
52.7
x
|
44.7
x
|
29.1
x
|
FCF Yield
|
0.23%
|
12%
|
1.28%
|
-5.07%
|
5.5%
|
1.9%
|
2.24%
|
3.43%
|
Price to Book
|
1.79
x
|
1.73
x
|
2.29
x
|
1.88
x
|
1.59
x
|
1.82
x
|
1.75
x
|
1.62
x
|
Nbr of stocks (in thousands)
|
185,442
|
185,442
|
185,442
|
185,441
|
180,950
|
180,958
|
-
|
-
|
Reference price
2 |
1,612
|
1,703
|
2,473
|
2,167
|
1,900
|
2,438
|
2,438
|
2,438
|
Announcement Date
|
4/5/19
|
4/7/20
|
4/6/21
|
4/5/22
|
4/4/23
|
4/2/24
|
-
|
-
|
Fiscal Period: February |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
488,464
|
541,964
|
602,510
|
625,477
|
667,647
|
744,477
|
843,769
|
912,335
|
EBITDA
1 |
33,206
|
38,174
|
43,641
|
43,405
|
44,020
|
49,659
|
53,484
|
57,830
|
EBIT
1 |
25,817
|
29,762
|
33,701
|
32,137
|
31,658
|
36,632
|
39,799
|
42,712
|
Operating Margin
|
5.29%
|
5.49%
|
5.59%
|
5.14%
|
4.74%
|
4.92%
|
4.72%
|
4.68%
|
Earnings before Tax (EBT)
1 |
26,053
|
29,926
|
31,521
|
27,456
|
28,184
|
32,102
|
36,169
|
38,965
|
Net income
1 |
17,940
|
20,782
|
21,120
|
19,389
|
19,007
|
21,979
|
24,508
|
26,381
|
Net margin
|
3.67%
|
3.83%
|
3.51%
|
3.1%
|
2.85%
|
2.95%
|
2.9%
|
2.89%
|
EPS
2 |
95.91
|
112.1
|
113.9
|
104.6
|
103.8
|
121.5
|
135.4
|
145.8
|
Free Cash Flow
1 |
532
|
26,931
|
4,773
|
-16,718
|
15,023
|
8,065
|
8,449
|
12,699
|
FCF margin
|
0.11%
|
4.97%
|
0.79%
|
-2.67%
|
2.25%
|
1.08%
|
1%
|
1.39%
|
FCF Conversion (EBITDA)
|
1.6%
|
70.55%
|
10.94%
|
-
|
34.13%
|
11.54%
|
15.8%
|
21.96%
|
FCF Conversion (Net income)
|
2.97%
|
129.59%
|
22.6%
|
-
|
79.04%
|
36.69%
|
34.48%
|
48.14%
|
Dividend per Share
2 |
23.33
|
26.67
|
26.67
|
26.67
|
26.67
|
26.67
|
32.96
|
36.63
|
Announcement Date
|
4/5/19
|
4/7/20
|
4/6/21
|
4/5/22
|
4/4/23
|
4/2/24
|
-
|
-
|
Fiscal Period: February |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
263,701
|
278,263
|
302,598
|
299,912
|
159,784
|
314,955
|
151,573
|
158,949
|
161,128
|
171,283
|
332,411
|
163,580
|
171,656
|
177,851
|
188,713
|
366,564
|
184,568
|
193,345
|
195,381
|
206,038
|
404,700
|
214,510
|
224,645
|
EBITDA
|
-
|
-
|
-
|
-
|
11,591
|
-
|
9,633
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
14,776
|
14,986
|
18,507
|
15,194
|
8,869
|
16,131
|
7,150
|
8,856
|
6,671
|
8,784
|
15,455
|
6,445
|
9,758
|
7,778
|
9,509
|
17,287
|
8,607
|
10,738
|
8,835
|
10,281
|
19,000
|
9,291
|
12,518
|
Operating Margin
|
5.6%
|
5.39%
|
6.12%
|
5.07%
|
5.55%
|
5.12%
|
4.72%
|
5.57%
|
4.14%
|
5.13%
|
4.65%
|
3.94%
|
5.68%
|
4.37%
|
5.04%
|
4.72%
|
4.66%
|
5.55%
|
4.52%
|
4.99%
|
4.69%
|
4.33%
|
5.57%
|
Earnings before Tax (EBT)
|
15,657
|
14,269
|
18,758
|
12,763
|
-
|
14,729
|
7,308
|
-
|
6,804
|
-
|
13,361
|
7,655
|
-
|
8,173
|
-
|
15,260
|
8,883
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
10,461
|
10,321
|
12,555
|
8,565
|
4,857
|
9,836
|
4,914
|
4,639
|
4,608
|
4,369
|
8,977
|
5,189
|
4,841
|
5,563
|
4,702
|
10,265
|
5,980
|
5,734
|
6,299
|
5,641
|
-
|
6,501
|
6,735
|
Net margin
|
3.97%
|
3.71%
|
4.15%
|
2.86%
|
3.04%
|
3.12%
|
3.24%
|
2.92%
|
2.86%
|
2.55%
|
2.7%
|
3.17%
|
2.82%
|
3.13%
|
2.49%
|
2.8%
|
3.24%
|
2.97%
|
3.22%
|
2.74%
|
-
|
3.03%
|
3%
|
EPS
2 |
56.41
|
-
|
67.70
|
-
|
26.19
|
53.05
|
26.50
|
25.02
|
24.85
|
23.67
|
48.53
|
28.56
|
26.73
|
30.75
|
25.98
|
56.73
|
33.05
|
31.68
|
34.53
|
29.63
|
-
|
34.54
|
39.80
|
Dividend per Share
2 |
13.33
|
-
|
13.33
|
-
|
-
|
13.33
|
-
|
-
|
-
|
-
|
13.33
|
-
|
-
|
-
|
-
|
13.33
|
-
|
13.33
|
-
|
15.00
|
-
|
-
|
20.00
|
Announcement Date
|
9/24/19
|
4/7/20
|
9/29/20
|
4/6/21
|
9/28/21
|
9/28/21
|
12/28/21
|
4/5/22
|
6/28/22
|
9/27/22
|
9/27/22
|
12/27/22
|
4/4/23
|
6/27/23
|
9/26/23
|
9/26/23
|
12/26/23
|
4/2/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: February |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
65,311
|
91,347
|
86,845
|
71,831
|
70,642
|
68,480
|
63,773
|
71,405
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
532
|
26,931
|
4,773
|
-16,718
|
15,023
|
8,065
|
8,449
|
12,699
|
ROE (net income / shareholders' equity)
|
10.9%
|
11.9%
|
11%
|
9.4%
|
8.8%
|
9.8%
|
10.1%
|
10%
|
ROA (Net income/ Total Assets)
|
10.5%
|
10.9%
|
6.4%
|
5.7%
|
9.43%
|
10.2%
|
7.88%
|
7.6%
|
Assets
1 |
171,078
|
191,239
|
330,000
|
340,345
|
201,464
|
214,497
|
311,214
|
347,118
|
Book Value Per Share
2 |
898.0
|
985.0
|
1,082
|
1,153
|
1,197
|
1,290
|
1,394
|
1,503
|
Cash Flow per Share
2 |
135.0
|
157.0
|
167.0
|
165.0
|
171.0
|
199.0
|
225.0
|
241.0
|
Capex
1 |
18,078
|
20,387
|
21,563
|
20,743
|
15,252
|
30,529
|
33,475
|
30,585
|
Capex / Sales
|
3.7%
|
3.76%
|
3.58%
|
3.32%
|
2.28%
|
4.11%
|
3.97%
|
3.35%
|
Announcement Date
|
4/5/19
|
4/7/20
|
4/6/21
|
4/5/22
|
4/4/23
|
4/2/24
|
-
|
-
|
Last Close Price
2,438
JPY Average target price
2,656
JPY Spread / Average Target +8.96% Consensus |
1st Jan change
|
Capi.
|
---|
| +12.84% | 2.84B | | -13.36% | 3.6B | | -25.52% | 3.01B | | +16.93% | 2.83B | | -2.81% | 1.9B | | +11.42% | 1.41B | | -20.60% | 970M | | -38.18% | 709M | | -0.53% | 465M | | +6.33% | 405M |
Retail - Drugs with Grocery
|